Patents Represented by Attorney Albert Tockman
-
Patent number: 4772370Abstract: A method for producing quasi-crystalline films by direct vapor deposition through sputtering is provided. The method is applicable to all alloys which can be converted to quasi-crystalline structure by melt spinning.Type: GrantFiled: June 23, 1987Date of Patent: September 20, 1988Assignee: The United States of America as represented by the Secretary of CommerceInventor: Kenneth G. Kreider
-
Patent number: 4772745Abstract: Photosensitive anthracene compounds containing two anthracene rings joined by a flexible linkage, and containing a functional group as an annular substituent on one of the anthracene rings, react with polymers to form materials useful in information proceedings.Type: GrantFiled: August 18, 1986Date of Patent: September 20, 1988Assignee: The United States of America as represented by the Secretary of CommerceInventors: Qui Tran-Cong, Charles C. Han
-
Patent number: 4771022Abstract: Toughening agents are produced by the application of high pressure, sufficient to transform a powder material into a denser high pressure polymorph. When the pressure is released, the high pressure phase is retrieved metastably at ambient conditions of pressure and temperature. The amount of high pressure phase retained at ambient conditions depends on the relative hydrostaticity of the pressurized environment and particle size of the powder. The high pressure phase is almost completely retained in a hydrostatic environment. One embodiment of the process of the present invention produces pressure transformation toughened zirconia comprising a high pressure phase having a symmetry no greater than tetragonal (defined as tetragonal II) dispersed within a matrix of a less dense monoclinic phase.Type: GrantFiled: February 18, 1987Date of Patent: September 13, 1988Assignee: The United States of America as represented by the Secretary of CommerceInventors: Stanley Block, Gasper J. Piermarini
-
Patent number: 4719180Abstract: A synthetic gene characterised in that it codes for the expression of urogastrone or a sub-unit thereof is disclosed.The production thereof by the assembly and ligation of a number of nucleotide blocks is also disclosed, as are corresponding plasmid recombinants, transformed cells and the production thereof.The expression of urogastrone is further disclosed.Urogastrone is a polypeptide hormore (protein) which may be isolated in small amounts from human urine. It has an application in the treatment of ulcers and in the promotion of wound healing. The present invention provides a more viable commercial production.Type: GrantFiled: September 13, 1984Date of Patent: January 12, 1988Assignee: G. D. Searle & Co.Inventors: Michael A. W. Eaton, Michael T. Doel, Norman H. Carey, John C. Smith, David M. J. Lilley, Leslie D. Bell
-
Patent number: 4692280Abstract: Fish oil is purified by extraction with supercritical carbon dioxide.Type: GrantFiled: December 1, 1986Date of Patent: September 8, 1987Assignee: The United States of America as represented by the Secretary of CommerceInventors: John Spinelli, Virginia F. Stout, William B. Nilsson
-
Patent number: 4675132Abstract: Polyunsaturated fatty acid moieties in fish oil are concentrated by transesterifying fish oil glycerides with a lower alkanol to form a mixture of lower alkyl fatty acid esters, and extracting the esters with carbon dioxide under supercritical conditions.Type: GrantFiled: June 24, 1986Date of Patent: June 23, 1987Assignee: The United States of America as represented by the Secretary of CommerceInventors: Virginia F. Stout, John Spinelli
-
Patent number: 4606902Abstract: Refractory borides or carbides are prepared by contacting an alkali-metal ducible metal chloride or silicon tetrachloride with boron trichloride or carbon tetrachloride in an inert solvent in the presence of an alkali metal, the metal chloride or silicon tetrachloride and the boron trichloride or carbon tetrachloride being present in an amount about stoichiometrically equivalent to the boride or carbide to be prepared and the alkali metal being present in an amount about stoichiometrically equivalent to the amount of chloride in the metal chloride or silicon tetrachloride and the boron trichloride or carbon tetrachloride, until all chloride present has reacted with the alkali metal to form alkali metal chloride, separating the inert solvent to leave a solid residue containing a metal boride, silicon carbide or metal carbide precursor together with the alkali metal chloride, and calcining the residue while separating the alkali metal chloride until the precursor is converted to the refractory boride or carbideType: GrantFiled: October 3, 1985Date of Patent: August 19, 1986Assignee: The United States of America as represented by the Secretary of CommerceInventor: Joseph J. Ritter
-
Patent number: 4399279Abstract: 4H-1,4 benzothiazine derivatives having anorectic activity and their preparation including intermediate compounds are disclosed.Type: GrantFiled: April 30, 1982Date of Patent: August 16, 1983Assignee: G.D. Searle & Co.Inventors: Robert J. Chorvat, Bipinchandra N. Desai, Suzanne E. Radak
-
Patent number: 4396777Abstract: 1-Cycloalkyl phosphonium salts represented by the formula ##STR1## wherein: R is selected from the group consisting of lower alkyl, hydroxy lower alkyl, halo lower alkyl, amino lower alkyl, cyano lower alkyl, lower alkenyl with the limitation that the double bond is not on the carbon atom attached to the oxygen atom, benzyl, substituted benzyl and ##STR2## wherein q is O or 1 and R.sub.4 is selected from the group consisting of hydroxy, loweralkoxy, phenyl, substituted phenyl, and ##STR3## wherein R.sub.5 and R.sub.6 are the same or different members of the group consisting of hydrogen and loweralkyl or taken together form a 5 or 6 membered ring; m is 1, 2 or 3; n is 0 or 1; o is 0 or 1; p is 0 or 1; R.sub.1, R.sub.2 and R.sub.3 are the same or different members of the group consisting of hydrogen, lower alkyl, lower alkoxy and halo; and X is a pharmaceutically acceptable anion. The compounds are useful as analgesic agents.Type: GrantFiled: March 29, 1982Date of Patent: August 2, 1983Assignee: G. D. Searle & Co.Inventor: Richard A. Mueller
-
Patent number: 4395341Abstract: The invention relates to the use of metronidazole as an improved bactericidal agent in flooding waters used in oil recovery operations.Type: GrantFiled: September 8, 1981Date of Patent: July 26, 1983Assignee: G. D. Searle & Co.Inventor: Robert D. Muir
-
Patent number: 4388308Abstract: N.sup.6 -2-hydroxypropylaryl-substituted adenosines and adenines represented by the formula ##STR1## wherein R.sub.1 is selected from the group consisting of naphthyl, phenyl, substituted phenyl or biphenyl; and R.sub.2 is hydrogen or 1-.beta.-ribosyl; and the pharmaceutically acceptable salts thereof. The compounds are anti-hypertensive agents.Type: GrantFiled: June 9, 1980Date of Patent: June 14, 1983Assignee: G.D. Searle & Co.Inventors: Robert W. Hamilton, Richard E. L. Henderson, Barnett S. Pitzele
-
Patent number: 4377697Abstract: Compounds of the general formulae: ##STR1## in which Ar and Ar.sup.1 which may be the same or different represent aromatic radicals optionally substituted once or more than by substituents selected from halogen, lower alkyl and lower alkoxy and Alk represents an alkylene group containing from 1 to 4 carbon atoms which alkylene group may be interrupted with a heteroatom; and acid addition salts thereof.These compounds have anti-anaerobe and also anti-fungal activity and are non-mutagenic.Type: GrantFiled: February 2, 1982Date of Patent: March 22, 1983Assignee: G. D. Searle & Co.Inventors: Peter J. Fellner, George Ellames, Christopher D. Floyd, Paul W. Manley
-
Patent number: 4376766Abstract: The use of an anti-sickling agent of one or more of L-lysine-L-phenylalanine, L-lysine-L-tyrosine, L-histidine-L-lysine-L-tyrosine-L-histidine, in particular L-lysine-L-phenylalanine, and salts thereof is disclosed.An anti-sickling composition which comprises one or more of L-lysine-L-phenylalanine, L-lysine-L-tyrosine, L-histidine-L-lysine-L-tyrosine-L-histidine and salts thereof in association with one or more sterile, pharmaceutically-acceptable carriers, diluents and adjuvants is also disclosed.Type: GrantFiled: July 24, 1981Date of Patent: March 15, 1983Assignee: G.D. Searle & Co.Inventors: Rosalind I. Collinson-Jones, John F. Pardon
-
Patent number: 4357421Abstract: A process for the production of a synthetic gene for an influenza haemagglutinin which comprises:(a) subjecting isolated vRNA to the action of reverse transcriptase to produce a double-stranded RNA/DNA hybrid;(b) digesting the RNA component of the hybrid;(c) treating the residual DNA component of the hybrid to produce a double-stranded DNA molecule having one "hairpin" end; and(d) treating the "hairpin" structure with a single-strand specific nuclease to produce a bimolecular double-stranded copy of the vRNA.Type: GrantFiled: March 24, 1980Date of Patent: November 2, 1982Assignee: G. D. Searle & Co.Inventors: John S. Emtage, Norman H. Carey
-
Patent number: 4356302Abstract: 4H-1,4 benzothiazine derivatives having anorectic activity and their preparation including intermediate compounds are disclosed.Type: GrantFiled: March 9, 1981Date of Patent: October 26, 1982Assignee: G. D. Searle & Co.Inventors: Robert J. Chorvat, Bipinchandra N. Desai, Suzanne E. Radak
-
Patent number: 4355182Abstract: Hydroxy-substituted phosphoranes and salts thereof represented by Formulae I and II ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different members of the group consisting of lower alkyl, C.sub.5 -C.sub.6 cycloalkyl, and ##STR2## wherein q is an integer from 0 to 4 and Y is selected from the group consisting of hydrogen, halogen, lower alkyl and lower alkoxy; R.sub.4 can be hydrogen or C.sub.1 -C.sub.3 straight or branched chain alkyl; the sum of n+m=3-5; R.sub.5 is hydrogen or lower alkyl; R.sub.6 and R.sub.7 are the same or different members of the group consisting of hydrogen, lower alkyl, and ##STR3## p is an integer of 0 or 1; and X is an anion. The compounds are useful as intermediates for the heterocyclic phosphonium salts disclosed and claimed in U.S. Pat. No. 4,075,407. An improved process for preparing the phosphonium salts of U.S. Pat. No. 4,075,407 is also provided by the present invention.Type: GrantFiled: July 28, 1980Date of Patent: October 19, 1982Assignee: G.D. Searle & Co.Inventor: Richard A. Mueller
-
Patent number: 4351948Abstract: Compounds corresponding to the following general formula: ##STR1## wherein Ar and Ar.sup.1, which may be the same or different, each represents an aromatic radical which may be substituted one or more times by halogen and/or nitro and/or lower alkyl and/or trihalomethyl and/or cyano and/or lower alkoxy and/or di-lower alkyl-amino, the alkyl groups optionally completing a ring optionally incorporating a further heteroatom, and/or lower alkyl sulphonyl;Alk.sup.1 and Alk.sup.2, which may be the same or different, each represents an alkylene group containing from one to eight carbon atoms which may be substituted one or more times by aryl and/or cycloalkyl and/or lower alkyl and if two such alkyl groups are present, they may complete a ring optionally containing a heteroatom and in which imidazole ring may be further substituted; and m represents 0 or 1; provided that not both Ar and Ar.sup.1 represent phenyl; and acid addition salts thereof.Type: GrantFiled: January 16, 1981Date of Patent: September 28, 1982Assignee: G.D. Searle & Co.Inventors: Peter J. Fellner, Brendan J. Hamill, Paul W. Manley
-
Patent number: 4349629Abstract: A plasmid having an insertion site for a eukaryotic DNA fragment adjacent to a bacterial promoter and downstream from a prokaryotic ribosome binding site and initiator codon such that the bacterial promoter controls transcription and translation of an inserted DNA fragment is disclosed.The production and use of such plasmids is also disclosed.In general terms, one aspect of the present invention relates to a series of plasmid vectors having the basic characteristic of a Hind III insertion site adjacent to a tryptophan promoter and also a gene for tetracycline resistance. The plasmid vectors are by virtue of the structure thereof ideally suited to receive at the Hind III site an inserted eukaryotic DNA fragment the transcription and translation of which is under the control of the tryptophan promotor.Type: GrantFiled: May 29, 1980Date of Patent: September 14, 1982Assignee: G.D. Searle & Co.Inventors: Norman H. Carey, John S. Emtage, William C. A. Tacon, Robert A. Hallewell
-
Patent number: 4348388Abstract: 11-Amino-11-deoxydaunorubicin and analogs represented by the formula: ##STR1## wherein: R is hydrogen, hydroxy or methoxy; R.sub.1 is hydrogen or hydroxy; and the pharmaceutically acceptable salts thereof.The compounds are useful in ameliorating tumor growth.Type: GrantFiled: April 2, 1980Date of Patent: September 7, 1982Assignee: G.D. Searle & Co.Inventors: Robert B. Garland, Raphael Pappo, Paul B. Sollman
-
Patent number: 4347192Abstract: Derivatives of .alpha.,.beta.-unsaturated ketones having anticonvulsant activity and methods of their preparation from heterocyclic phosphonium salts and acyclic phosphoranes are disclosed.Type: GrantFiled: July 24, 1980Date of Patent: August 31, 1982Assignee: G. D. Searle & Co.Inventor: Richard A. Mueller